Wei Zheng
Fondatore presso Suzhou Connect Biopharma Co. Ltd.
Posizioni attive di Wei Zheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Direttore/Membro del Consiglio | 02/05/2012 | - |
| Amministratore Delegato | 02/05/2012 | - | |
| Fondatore | 02/05/2012 | - |
Storia della carriera di Wei Zheng
Formazione di Wei Zheng
| University of California, Davis | Doctorate Degree |
Statistiche
Distribuzione geografica
| Cina | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
- Borsa valori
- Insiders
- Wei Zheng
- Esperienza
